Eltanexor Effectively Reduces Viability of Glioblastoma and Glioblastoma Stem-Like Cells at Nano-Molar Concentrations and Sensitizes to Radiotherapy and Temozolomide

Katharina Otte(Philipps University of Marburg), Tillmann Rusch(Goethe University Frankfurt)
Biomedicines
August 31, 2022
Cited by 4


Related Papers